期刊文献+

益气活血化瘀汤对早期糖尿病肾病大鼠肾脏MCP-1及nephrin表达的影响 被引量:4

下载PDF
导出
摘要 目的:观察益气活血化瘀汤对DN大鼠肾组织MCP-1及nephrin表达的影响,探讨其对DN的保护作用机制。方法:48只SD雄性大鼠行单侧肾切除术,随机分为正常组和DN组,DN组通过一次性腹腔注射链脲佐菌素60mg/kg建立DN大鼠模型,再随机分为3组:模型组、中药组及氯沙坦组。各组分别干预12周后,免疫组化法及实时荧光定量PCR法检测肾组织MCP-1和nephrin蛋白及mRNA表达。结果:与模型组相比,中药及氯沙坦干预后,DN大鼠肾组织MCP-1表达明显减少(P<0.05),而nephrin表达显著增多(P<0.05)。结论:益气活血化瘀汤对早期糖尿病肾病大鼠具有一定肾脏保护作用,其机制可能是通过下调MCP-1的表达,上调nephrin的表达,抑制炎症反应。
出处 《浙江中医杂志》 2014年第11期843-845,共3页 Zhejiang Journal of Traditional Chinese Medicine
  • 相关文献

参考文献9

  • 1Martinez FO, Helming L,Gordon S. Alternative activation of macrophages: an immunologic functional perspective[J]. Annual review of immunology, 2009,27 : 451-483.
  • 2Advani A,Wiggins K J,Cox A J,et al. Inhibition of the epi- dermal growth factor receptor preserves podocytes and attenuates albuminuria in experimental diabetic nephropathy[J]. Nephrology,2011,16(6):573-581.
  • 3李伟,张红,殷松楼,褚璇.不同剂量链脲佐菌素诱导SD大鼠糖尿病肾病模型的研究[J].徐州医学院学报,2006,26(1):52-55. 被引量:55
  • 4Tuttle K R. Linking metabolism and immunology: diabetic nephropathy is an inflammatory disease[J].Journal of the Amer iean Society of Nephrology,2005,16(6) : 1537-1538.
  • 5Yadav A, Saini V, Arora S. MCP-1 : chemoattractant with a role beyond immunity: a review[J]. Clinica chimica acta, 2010, 411(21):1570-1579.
  • 6Vallon V. The proximal tubule in the pathophysiology of the diabetic kidney[J]. American Journal of Physiology Regulatory, Integrative and Comparative Physiology,2011,300(5): R1009.
  • 7马丽娟,杜国利,吕文魁,曾小云,朱筠.氯沙坦钾对2型糖尿病肾病大鼠肾脏TGF-β_1、CD68和MCP-1表达的影响[J].中国病理生理杂志,2012,28(5):947-950. 被引量:19
  • 8Jim B,Ghanta M,Qipo A,et al. Dysregulated nephrin in dia- betic nephropathy of type 2 diabetes: a cross sectional study[J]. PLoS One,2012,7(5): e36041.
  • 9MacIsaac R J, Jerums G. Diabetic kidney disease with and without albuminuria[J]. Current opinion in nephrology and hy- pertension,2011,20(3) : 246-257.

二级参考文献23

  • 1李聪然,游雪甫,蒋建东.糖尿病动物模型及研究进展[J].中国比较医学杂志,2005,15(1):59-63. 被引量:93
  • 2于德民,吴锐,尹潍,袁咏.实验性链脲佐菌素糖尿病动物模型的研究[J].中国糖尿病杂志,1995,3(2):105-109. 被引量:425
  • 3Baylis C, Atzpodien EA, Freshour G, et al. Peroxisome proliferator activated receptor L gamma agonist provides superior renal protection versus angiotensin - converting enzyme inhibition in a rat model of type 2 diabetes with obesity [J]. J Pharmacol Exp Ther, 2003, 307 ( 3 ) : 854 -860.
  • 4Hill C,Flyvbjerg A, Gronbaek H,et al,The renal expression of transforming growth factor- β isoforms and their receptors in acute and chronic experimental diabetes in rats [J]. Endocrinology, 2000, 141(3) : 1196 - 1208.
  • 5Gross ML, Ritz E, Schoof A, et al, Comparison of renal morphology in the streptozotocin and the SHR/N- cp nmdels of diabetes[J]. Lab Invest,2004,84(4) :452 - 464.
  • 6Wehbi GJ, Zimpelmann J, Carey RM, et al. Early streptozotocin- diabetes mellitus downre.gulates rat kidney AT2 receptors[J]. Am J Physiol Renal Physiol,2001,280(2) :F254 - F265.
  • 7王禹斌 周正宇 薛智谋.人类疾病动物模型[M].邵义祥主编.医学实验动物学[C].南京:东南大学出版社,2003.253-259.
  • 8Mora C, Navarro JF. The role of inflammation as a pathogenic factor in the development of renal disease in diabetes [ J]. Curr Diab Rep,2005,5 (6) :399 -401.
  • 9US Renal Data System. USRDS 2010 annual data report: atlas of chronic kidney disease and end - stage renal disease in the United States [EB/OL]. Bethesda: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010 [ 2010 -12 -20 ]. http ://www. usrds, org/2010/ADR_booklet_2010_lowres. pdf, http ://www. usrds. org/2009/pdf/V2 02 INC_PREV _09. PDF.
  • 10Matavelli LC, Huang J, Siragy HM (Pro)renin receptor contributes to diabetic nephropathy by enhancing renal in- flammation [J]. J Clin Exp Pharmacol Physiol,2010,37 (3) :277 -282.

共引文献72

同被引文献81

引证文献4

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部